Medications for Primary Immune Deficiency Disorder

3 results
  • cutaquig

    (Immunoglobulin G)
    Pfizer Laboratories Div Pfizer Inc
    Cutaquig is a subcutaneous immune globulin solution indicated as replacement therapy for primary humoral immunodeficiency (PI) in adults and pediatric patients 2 years and older, including CVID, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
  • hizentra

    (Human Immunoglobulin G)
    Csl Behring Ag
    Hizentra is indicated as replacement therapy for primary humoral immunodeficiency (PI) in adults and pediatric patients aged 2 and older, and as maintenance therapy to prevent relapse of neuromuscular disability and impairment in adults with chronic inflammatory demyelinating polyneuropathy (CIDP).
  • xembify

    (Immune Globulin Subcutaneous, Human-Klhw)
    Grifols Usa, Llc
    Xembify is a 20% immune globulin solution for subcutaneous injection indicated for primary humoral immunodeficiency (PI) in patients 2 years and older, including congenital agammaglobulinemia, common variable immunodeficiency, X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.